- DermaLumics, a medical device manufacturer, presents NITID, a non-invasive and highly portable skin imaging solution for dermatologists.
- The new hand-held device combines three imaging modalities – including Optical Coherence Tomography (OCT) to optimize skin cancer diagnostics.
- NITID will be presented at the DermaLumics booth number 6 at the 4th World Congress of Dermoscopy and Skin Imaging 2015, Vienna (Austria).
Madrid, April 16, 2015. DermaLumics presents NITID*, an innovative, non-invasive diagnosis tool for skin surface using Optical Coherence Tomography (OCT), at the 4th World Congress of Dermoscopy and Skin Imaging 2015, Vienna (Austria). The hand-held device allows physicians to identify different skin structures, inflammations, vascularization and it is a very useful tool for the detection of tumoral nodules especially in non-melanoma skin cancer (NMSC).
To cater to the special needs and requirements of dermatology patients, DermaLumics was founded in 2015 as a spin-off from the Spanish medical device company MedLumics, founded in 2009. MedLumics’ goal is to turn the latest technological developments in biophotonics into innovative medical products of high value to improve patients’ quality of life.
NITID is a result of thorough research on clinical needs in the field of skin care. “NITID is a versatile multi-purpose solution customized for dermatologists. It combines micrometerresolution modality with a digital epiluminescence microscope and a lesion documentation system in a battery-operated portable device designed for daily use. “, says Miguel Eslava, general manager of DermaLumics. “It is our goal to become one of the leading providers of hand-held, ultra compact diagnostic devices in the field of skin care.”
NITID allows for a real-time diagnosis with high sensitivity and specificity, analyzing skin up to 2mm deep. It includes an Electronic Dermatology Recording (EDR) system that allows the safe and efficient storage of data. DermaLumics managed to combine Clinical Image (CI), Digital Dermatoscope (DD) and Optical Coherence Tomography (OCT) in one portable solution that provides dermatologists with excellent results.
“OCT enables non-invasive optical biopsy, such as real time, in situ imaging of tissue microstructure, with a resolution approaching that of histology, but without the need for tissue excision and post-processing. From the viewpoint of screening and diagnosis of diseases, OCT might enable significantly new insight in the pathogenesis, early diagnosis and therapy control of several diseases but only if low-cost, miniaturized, high performance systems are available. NITID from DermaLumics is the first commercial clinical OCT product based on integrated optics enabling multi-modality imaging but also the worldwide smallest, cost-effective OCT system that has the potential to revolutionize dermatologic diagnosis,” says OCT pioneer, Prof. Wolfgang Drexler, Head of the Center of Medical Physics and Biomedical Engineering at the University of Vienna.
Since the device allows increasing patient flow and helps to reduce the number of biopsies on a large scale, both patients and healthcare professionals can benefit from DermaLumics’ innovation.
DermaLumics is a new medical device company focusing on the dermatology market. Being a spin-off of MedLumics, DermaLumics is committed to transforming progress in the science and technology of light into high-quality innovative products improving human living standards worldwide. By expanding the clinical indications for optical coherence tomography, through a new class of hand-held and ultra-compact devices, DermaLumics is to become a major player for this new diagnostic imaging technique.
www.dermalumics.com
*Pending CE Mark
For more information
Sebastián Montero
[email protected]
Tel. 0034 91 804 3928
